The stock of Ardelyx Inc (ARDX) has gone down by -0.59% for the week, with a 6.60% rise in the past month and a -7.02% drop in the past quarter. The volatility ratio for the week is 4.64%, and the volatility levels for the past 30 days are 6.80% for ARDX. The simple moving average for the past 20 days is 2.26% for ARDX’s stock, with a -8.90% simple moving average for the past 200 days.
Is It Worth Investing in Ardelyx Inc (NASDAQ: ARDX) Right Now?
Moreover, the 36-month beta value for ARDX is 0.87. Analysts have varying opinions on the stock, with 8 analysts rating it as a “buy,” 0 as “overweight,” 2 as “hold,” and 0 as “sell.”
The public float for ARDX is 227.39M and currently, short sellers hold a 10.39% of that float. On February 04, 2025, ARDX’s average trading volume was 4.94M shares.
ARDX) stock’s latest price update
The stock of Ardelyx Inc (NASDAQ: ARDX) has increased by 3.17 when compared to last closing price of 5.29. Despite this, the company has experienced a -0.59% fall in its stock price over the last five trading sessions. globenewswire.com reported 2025-01-30 that WALTHAM, Mass., Jan. 30, 2025 (GLOBE NEWSWIRE) — Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced it will hold a conference call on Thursday, February 20, 2025, at 8:00 a.m.
Analysts’ Opinion of ARDX
Many brokerage firms have already submitted their reports for ARDX stocks, with H.C. Wainwright repeating the rating for ARDX by listing it as a “Neutral.” The predicted price for ARDX in the upcoming period, according to H.C. Wainwright is $5.50 based on the research report published on November 11, 2024 of the previous year 2024.
Piper Sandler, on the other hand, stated in their research note that they expect to see ARDX reach a price target of $7, previously predicting the price at $15. The rating they have provided for ARDX stocks is “Neutral” according to the report published on July 02nd, 2024.
Leerink Partners gave a rating of “Outperform” to ARDX, setting the target price at $14 in the report published on April 05th of the previous year.
ARDX Trading at 4.14% from the 50-Day Moving Average
After a stumble in the market that brought ARDX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -46.12% of loss for the given period.
Volatility was left at 6.80%, however, over the last 30 days, the volatility rate increased by 4.64%, as shares surge +9.46% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +13.57% upper at present.
During the last 5 trading sessions, ARDX fell by -0.91%, which changed the moving average for the period of 200-days by -16.95% in comparison to the 20-day moving average, which settled at $5.34. In addition, Ardelyx Inc saw 7.65% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ARDX starting from RAAB MICHAEL, who sale 41,666 shares at the price of $5.36 back on Jan 31 ’25. After this action, RAAB MICHAEL now owns 1,108,719 shares of Ardelyx Inc, valued at $223,355 using the latest closing price.
MOTT DAVID M, the Director of Ardelyx Inc, purchase 199,000 shares at $4.99 during a trade that took place back on Jan 21 ’25, which means that MOTT DAVID M is holding 1,937,765 shares at $992,672 based on the most recent closing price.
Stock Fundamentals for ARDX
Current profitability levels for the company are sitting at:
- -0.25 for the present operating margin
- 0.85 for the gross margin
The net margin for Ardelyx Inc stands at -0.29. The total capital return value is set at -0.22. Equity return is now at value -41.54, with -22.09 for asset returns.
Based on Ardelyx Inc (ARDX), the company’s capital structure generated 0.4 points at debt to capital in total, while cash flow to debt ratio is standing at -0.61. The debt to equity ratio resting at 0.66. The interest coverage ratio of the stock is -3.76.
Currently, EBITDA for the company is -55.35 million with net debt to EBITDA at -1.08. When we switch over and look at the enterprise to sales, we see a ratio of 5.32. The receivables turnover for the company is 4.73for trailing twelve months and the total asset turnover is 0.68. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.03.
Conclusion
To wrap up, the performance of Ardelyx Inc (ARDX) has been mixed in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
